impact factor
logo
 

One year in review

 

One year in review 2021: systemic sclerosis


1, 2, 3, 4, 5, 6, 7, 8

 

  1. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  2. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  3. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
  5. Rheumatology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  6. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. a.dellarossa@ao-pisa.toscana.it
  7. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
  8. Scleroderma Programme, NIHR BRC and Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.

CER14769
2021 Vol.39, N°4 ,Suppl.131
PI 0003, PF 0012
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 34251323 [PubMed]

Received: 30/04/2021
Accepted : 10/06/2021
In Press: 01/07/2021
Published: 28/07/2021

Abstract

Systemic sclerosis is a rare and chronic connective tissue disease with a multifaceted pathogenesis characterised by heterogeneous multi-organ clinical manifestations. Every year, many studies contribute to enrich the knowledge on the pathogenesis, organ involvement and treatment of this complex and severe disease. We herein provide an overview on the most relevant contributions published in the literature in 2020.

Rheumatology Article